Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
January 23, 2023
ASCO 2022: Equity, innovation and in-person
Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more
Patient-reported outcomes predict risk of not taking breast cancer drugs
From the Unger and Ramsey Labs, Cancer Epidemiology, Prevention & Control Program, Cancer Consortium
New studies highlight cancer inequities in hospice care, financial impacts
Analyses shared at ASCO annual meeting show lack of home hospice care for Medicaid patients during COVID-19; quantify financial hardships
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021
Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemotherapy
Project will focus on reducing unplanned emergency department visits through a remote monitoring system
A look at emerging sickle cell disease therapies
Teams at the University of Washington School of Pharmacy and Fred Hutch will model the clinical and economic burden of sickle cell disease and the potential benefits of emerging therapies
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Filling in the gap on prevalence of viral infections
From the Ramsey Group, Public Health Sciences Division
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
Cancer Research in 2019: Why we are counting on data science and tech to defeat cancer
Why we are counting on data science and tech to defeat cancer
Cancer Research in 2019: Why we are counting on data science and tech to defeat cancer
Why we are counting on data science and tech to defeat cancer
7 lung cancer misconceptions
Myths and misinformation still keep many people in the dark – and that’s bad news for their health
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
Fred Hutch, Microsoft partner to improve cancer care delivery
Project to flag treatment-related symptoms early is revealed at Seattle conference
Hutch health economics releases first public report on cancer care quality and cost
Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Counting cancer cures when calculating QALYs
From the Othus and Ramsey Labs, Public Health Sciences Division.